Beth Seidenberg

Beth Seidenberg

Direktör/Styrelseledamot på KYVERNA THERAPEUTICS, INC.

Förmögenhet: 7 M $ per 2026-06-30

69 år
Health Technology
Technology Services
Finance

Profil

Beth C.
Seidenberg
is the founder of Westlake Biopartners LLC, founded in 2018, serving as Founding Managing Director.
Current jobs include Chairman at Kate Therapeutics, Inc.; Director at Breathe Technologies, Inc., Auxogyn, Inc., Mango Health, Inc., Spruce Health, Inc., Tmunity Therapeutics, Inc., Cell Design Labs, Inc., Arsenal Biosciences, Inc., Jamanda Ltd., Electra Therapeutics, Inc., Star OpCo, Inc.; Lead Independent Director at Sagimet Biosciences, Inc. since 2025; Director at Expansion Therapeutics, Inc. since 2018; Independent Director at Kyverna Therapeutics, Inc. since 2018; Independent Director at Vera Therapeutics, Inc. since 2016; Independent Director at Latigo Biotherapeutics, Inc. since 2024; and Advisor at Kleiner Perkins Caufield & Byers LLC since 2005.
Former jobs include Chairman at Arresto BioSciences, Inc. and Flexus Biosciences, Inc.; Director at BioCryst Pharmaceuticals, Inc. (2005–2011), Tesaro, Inc. (2011–2019), RedBrick Health Corp., iPierian, Inc., Practice Fusion, Inc., ARMO Biosciences, Inc. (2012–2018), True North Therapeutics, Inc., Livongo Health, Inc., Rapt Therapeutics, Inc. (2015–2019); Independent Director at ACELYRIN, Inc. (2020–2025), Epizyme, Inc. (2008–2019), Atara Biotherapeutics, Inc. (2012–2023); Lead Independent Director at Progyny, Inc. (2022–2024); Chief Medical Officer & Senior Vice President at Amgen, Inc. (2002–2005); Senior Vice President-Global Development at Bristol Myers Squibb Co. (2002); Vice President at Merck & Co., Inc. (1998–2000); VP-Immunology, Pulmonary & Dermatology at Merck Research Laboratories Massachusetts LLC (2000); Researcher at National Institutes of Health.
Education includes undergraduate degree from Barnard College and doctorate from The University of Miami Leonard M.
Miller School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-05-21 135 565 ( 0,19 % ) 6 M $ 2026-06-30
2026-06-12 131 643 ( 0,22 % ) 1 M $ 2026-06-30
2026-05-27 21 727 ( 0,04 % ) 193 588 $ 2026-06-30

Aktiva positioner av Beth Seidenberg

FöretagPositionStart
SAGIMET BIOSCIENCES INC. Direktör/Styrelseledamot 2007-04-01
KYVERNA THERAPEUTICS, INC. Direktör/Styrelseledamot 2018-09-01
VERA THERAPEUTICS, INC. Direktör/Styrelseledamot 2016-06-01
LATIGO BIOTHERAPEUTICS, INC. Direktör/Styrelseledamot 2024-07-01
Konsult / Rådgivare 2005-05-01
Direktör/Styrelseledamot 2018-01-03
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Grundare 2018-09-01
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░ -

Tidigare kända positioner av Beth Seidenberg

FöretagPositionSlut
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Beth Seidenbergs erfarenhet

Beth Seidenbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

69

Första gradens relationer

40

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag40

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Government

Consumer Services

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Technology Services

Health Technology

Technology Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Beth Seidenberg